Technical Analysis for RSLS - Reshape Lifesciences Inc

Grade Last Price % Change Price Change
grade A 9.5 43.94% 2.9000
RSLS closed up 43.94 percent on Friday, January 17, 2020, on 14 percent of normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical RSLS trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 43.94%
Older signals for RSLS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


ReShape Lifesciences Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology, vBloc Therapy is designed to intermittently block the vagus nerve using electrical impulses. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; and ReShape Balloon system that uses balloon technology designed to take up room in the stomach to enable people lose weight. Its product portfolio also comprises ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.
Medicine Medical Specialties Clinical Medicine Obesity Metabolic Diseases Gastrointestinal Disorders Digestive System Surgery Vagus Nerve Laparoscopy

Is RSLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 9.5
52 Week Low 0.03
Average Volume 61,678
200-Day Moving Average 0.8248
50-Day Moving Average 2.9566
20-Day Moving Average 5.6773
10-Day Moving Average 6.0625
Average True Range 0.6461
ADX 37.15
+DI 69.1417
-DI 15.7084
Chandelier Exit (Long, 3 ATRs ) 7.5617
Chandelier Exit (Short, 3 ATRs ) 6.6883
Upper Bollinger Band 7.5930
Lower Bollinger Band 3.7616
Percent B (%b) 1.5
BandWidth 67.4863
MACD Line 1.0706
MACD Signal Line 0.9680
MACD Histogram 0.1025
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.7750
Resistance 3 (R3) 13.3000 11.4000 13.0625
Resistance 2 (R2) 11.4000 10.3113 11.6375 12.8248
Resistance 1 (R1) 10.4500 9.6387 10.9250 10.9250 12.5874
Pivot Point 8.5500 8.5500 8.7875 8.7875 8.5500
Support 1 (S1) 7.6000 7.4613 8.0750 8.0750 6.4126
Support 2 (S2) 5.7000 6.7887 5.9375 6.1752
Support 3 (S3) 4.7500 5.7000 5.9375
Support 4 (S4) 5.2250